Best cannabis stocks to buy 2022?

Best cannabis stocks to buy in 2022

The cannabis industry is expected to explode in the next few years. Here are some of the best cannabis stocks to buy in 2022.

Aurora Cannabis (ACB)

Aurora Cannabis is one of the largest producers of cannabis in the world. The company is based in Canada and has operations in several countries. Aurora Cannabis is expected to benefit from the legalization of cannabis in Canada and other countries.

Canopy Growth (CGC)

Canopy Growth is another large producer of cannabis. The company is based in Canada and has operations in several countries. Canopy Growth is expected to benefit from the legalization of cannabis in Canada and other countries.

Aphria (APH)

Aphria is a leading producer of medical cannabis. The company is based in Canada and has operations in several countries. Aphria is expected to benefit from the legalization of cannabis in Canada and other countries.

OrganiGram (OGI)

OrganiGram is a leading producer of organic cannabis. The company is based in Canada and has operations in several countries. OrganiGram is expected to benefit from the legalization of cannabis in Canada and other countries.

Hexo (HEXO)

Hexo is a leading producer of cannabis-infused products. The company is based in Canada and has operations in several countries. Hexo is expected to benefit from the legalization of cannabis in Canada and other countries.

The best cannabis stocks to buy in 2022 are those that are expected to outperform the market and offer investors the potential for significant returns. While there are many factors to consider when selecting a stock, some of the most important include the company’s financial stability, growth potential, and competitive advantages.

It’s no secret that the cannabis industry is on the rise. In fact, it’s estimated to be worth $73.6 billion by 2027! With the industry growing at such a rapid pace, it’s no surprise that investors are eager to get in on the action. But with so many cannabis companies to choose from, it can be tough to know which ones are worth investing in.

When it comes to choosing the best cannabis stocks to buy in 2022, there are a few factors to consider. First and foremost, you’ll want to look for companies that are financially stable and have a strong growth potential. You’ll also want to look for companies that have a competitive advantage, such as a strong brand or a unique product.

Here are a few of the best cannabis stocks to buy in 2022:

Aurora Cannabis (ACB)

Aurora Cannabis is one of the largest cannabis companies in the world, with a market cap of $8.7 billion. The company is headquartered in Canada and is expected to generate $1.8 billion in sales in 2021. Aurora Cannabis is a great choice for investors who are looking for a financially stable company with a strong growth potential.

Cronos Group (CRON)

Cronos Group is a Canadian cannabis company with a market cap of $5.5 billion. The company is expected to generate $685 million in sales in 2021. Cronos Group is a great choice for investors who are looking for a company with a strong growth potential.

Canopy Growth (CGC)

Canopy Growth is a Canadian cannabis company with a market cap of $17.8 billion. The company is expected to generate $2.3 billion in sales in 2021. Canopy Growth is a great choice for investors who are looking for a company with a strong growth potential.

GW Pharmaceuticals (GWPH)

GW Pharmaceuticals is a UK-based cannabis company with a market cap of $4.4 billion. The company is expected to generate $480 million in sales in 2021. GW Pharmaceuticals is a great choice for investors who are looking for a company with a strong growth potential.

Here are three cannabis stocks to buy in 2022 that are expected to generate significant returns for investors:

The cannabis industry is expected to generate significant returns for investors in the coming years. Here are three cannabis stocks to buy in 2022 that are expected to generate significant returns for investors.

Aurora Cannabis Inc. (ACB)

Aurora Cannabis is a Canadian cannabis company that is expected to generate significant returns for investors in the coming years. The company is expected to benefit from the legalization of cannabis in Canada and the growing demand for cannabis products globally. Aurora Cannabis is expected to generate significant revenue and profit growth in the coming years.

Canopy Growth Corporation (CGC)

Canopy Growth is a Canadian cannabis company that is expected to generate significant returns for investors in the coming years. The company is expected to benefit from the legalization of cannabis in Canada and the growing demand for cannabis products globally. Canopy Growth is expected to generate significant revenue and profit growth in the coming years.

Aphria Inc. (APH)

Aphria is a Canadian cannabis company that is expected to generate significant returns for investors in the coming years. The company is expected to benefit from the legalization of cannabis in Canada and the growing demand for cannabis products globally. Aphria is expected to generate significant revenue and profit growth in the coming years.

Canopy Growth Corporation (CGC)

1 Canopy Growth Corporation (CGC) is a leading cannabis company that produces and sells a variety of cannabis products. The company has a strong presence in the Canadian and international markets, and its products are available in over 30 countries. Canopy Growth is dedicated to delivering high-quality cannabis products to patients and consumers around the world.

The company was founded in 2014, and it is headquartered in Smiths Falls, Ontario, Canada. Canopy Growth is a publicly traded company, and its shares are listed on the Toronto Stock Exchange (TSX:WEED) and the New York Stock Exchange (NYSE:CGC).

Canopy Growth is the largest cannabis company in the world, with a market capitalization of over $20 billion. The company has a portfolio of world-class cannabis brands, including Tweed, Spectrum Therapeutics, and Bedrocan. Canopy Growth is also the exclusive provider of cannabis products for the iconic Canadian company, Canopy Rivers.

Canopy Growth has a strong commitment to research and innovation, and it has a world-class research and development facility, Canopy Health Innovations. The company is also actively involved in the development of new cannabis products and technologies.

Canopy Growth is a leading player in the global cannabis market, and it is well-positioned to continue its growth in the years ahead.

Aurora Cannabis Inc. (

Aurora Cannabis Inc is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on both the Toronto Stock Exchange and the New York Stock Exchange. The company is a leading player in the global cannabis industry, with operations in 24 countries across five continents. Aurora is one of the world’s largest producers of medical cannabis and sells both medical and recreational cannabis products. The company has a diversified product range that includes dried cannabis, cannabis oils, and cannabis extracts. Aurora also offers a range of cannabis-infused products, such as edibles, beverages, and topicals. The company has a strong presence in both the Canadian and international cannabis markets and is one of the few companies with a license to sell cannabis products in all 10 provinces of Canada. Aurora has a growing network of over 1,800 retail locations across the country. The company’s products are also available in a number of international markets, including Germany, Italy, Spain, Portugal, the Czech Republic, and Poland.

Aurora Cannabis is one of the best-performing cannabis stocks in 2021, with the stock up over 400% since the start of the year. The company has been benefitting from strong demand for its products in both the Canadian and international markets. Aurora has also been benefiting from favorable industry trends, such as the increasing legalization of cannabis around the world. The company is well-positioned to continue its strong growth in the coming years and is one of the best cannabis stocks to buy for 2022.

Canopy Growth Corporation (CGC)

Canopy Growth Corporation (CGC) is a Canadian cannabis company that produces and sells medical and recreational cannabis products. The company is headquartered in Smiths Falls, Ontario, Canada. Canopy Growth is the world’s largest cannabis company by market capitalization, with a valuation of over $20 billion as of April 2021.

The company was founded in 2014 by Bruce Linton and Chuck Rifici. Canopy Growth was the first cannabis company to be listed on a major stock exchange, the Toronto Stock Exchange, in 2018. The company has operations in Canada, the United States, Europe, Australia, and South America.

Canopy Growth’s products include dried cannabis, cannabis oil, capsules, and pre-rolled joints. The company’s brands include Tweed, Spectrum Therapeutics, and Bedrocan. Canopy Growth has partnerships with Constellation Brands, a leading alcoholic beverage company, and Aphria, a leading Canadian cannabis company.

In October 2018, Canopy Growth became the first cannabis company to be listed on the New York Stock Exchange.

The company has been expanding rapidly and has made several acquisitions, including MediPharm Labs, a leading cannabis extractor, and Hiku Brands, a leading cannabis retail company.

Canopy Growth has been investing heavily in research and development, with a focus on developing new cannabis products and improving existing products. The company has also been working on developing new uses for cannabis, such as in the pharmaceutical and food and beverage industries.

Canopy Growth is one of the leading players in the global cannabis market and is well-positioned to continue its growth in the years ahead.

Aurora Cannabis Inc. (ACB)

Aurora Cannabis Inc (ACB) is one of the leading cannabis companies in the world with operations in 24 countries. The company produces and sells medical and recreational cannabis products. Aurora has a market capitalization of $8.4 billion and is traded on the Toronto Stock Exchange and the New York Stock Exchange.

Aurora was founded in 2013 by Terry Booth and Steve Dobler. The company is headquartered in Edmonton, Alberta, Canada. Aurora has over 2,500 employees and operates 10 production facilities with a total capacity of over 625,000 kilograms per year. The company sells its products in Canada, the European Union, the United Kingdom, and South America.

Aurora’s product offerings include dried cannabis, cannabis oils, and cannabis capsules. The company also offers hemp-derived CBD products. Aurora has partnerships with several major companies, including Coca-Cola, Anheuser-Busch InBev, and MedReleaf.

In October 2018, Aurora completed the acquisition of MedReleaf, a leading Canadian producer of medical cannabis, for $3.2 billion. The acquisition made Aurora the largest cannabis company in the world by market capitalization.

Aurora is well-positioned to capitalize on the growing global demand for cannabis. The company has a strong presence in key markets and a diversified product offering. Aurora is one of the best-positioned cannabis companies to benefit from the legalization of cannabis in Canada and other jurisdictions around the world.

Aphria Inc. (APHA)

Aphria Inc. (NYSE: APHA) is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of high-quality cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in our founders’ multi-generational expertise in commercial agriculture, Aphria develops and markets pharmaceutical-grade cannabis products for both the medical and adult-use markets.

Aphria has a diversified portfolio of assets across the globe. In Canada, the company operates Leamington, Ontario-based Aphria One, a state-of-the-art, indoor cannabis production facility with an annual capacity of 100,000 kg; and Aphria Diamond, a 1.3-million-square-foot, purpose-built greenhouse facility also in Leamington, with an annual capacity of 140,000 kg. In Argentina, Aphria owns 50% of Althea S.A., a licensed producer of medical cannabis products. In Germany, the company has a joint venture with Schroll Medical called Aphria Deutschland. And in Italy, Aphria has a 40% investment in ARA – Agrima Botanicals Srl.

Aphria’s products are sold through its adult-use brands, Solei, Good Supply Co. and Riff; and its medical brands, CanniMed and Aphria. The company has a strategic partnership with Southern Glazer’s Wine & Spirits, the largest wine and spirits distributor in North America. Through this partnership, Aphria is able to sell its products across Canada.

Aphria is a member of the United Nations Global Compact, the world’s largest corporate sustainability initiative, and has been named a Top 100 Employer in Canada for four consecutive years. The company is also

Tilray Inc. (TLRY)

4 Tilray Inc TLRY is a Canadian cannabis company with a market capitalization of $3.48 billion. The company was founded in 2013 and went public in 2018. Tilray is one of the leading international cannabis companies, with operations in 11 countries across 5 continents. The company produces and sells a variety of cannabis products, including dried cannabis, cannabis oils, and cannabis extracts. Tilray also offers a variety of CBD products.

Tilray has been a leader in the global cannabis industry, and its stock has performed well in recent years. The company’s stock price has more than tripled since going public in 2018. In 2020, Tilray was the top-performing stock on the Nasdaq Composite index.

Looking ahead, Tilray is well-positioned to continue its growth. The company has a strong management team, a large international footprint, and a diversified product portfolio. Tilray is also one of the few cannabis companies with a profitable business model.

As the global cannabis market continues to grow, Tilray is well-positioned to capitalize on this growth. The company is one of the best-positioned cannabis stocks to buy for 2022 and beyond.

Cronos Group Inc. (CRON)

Cronos Group Inc (NASDAQ: CRON) is a Canadian licensed cannabis producer. The company operates two wholly-owned licensed producers, Peace Naturals and Original BC, and holds a minority investment in Whistler Medical Marijuana Company. Cronos Group was founded in 2012 by Michael Gorenstein and Adam Greenstein. The company is headquartered in Toronto, Canada.

Cronos Group’s mission is to transform the global cannabis industry. The company’s vision is to build a leading, diversified global cannabis company. Cronos Group’s strategy is to invest in companies and platforms that provide differentiated products and services and that have the potential to generate long-term shareholder value.

Cronos Group’s common shares trade on the NASDAQ Global Select Market under the ticker symbol “CRON”.

Cronos Group is a publicly traded company with a market capitalization of approximately $2.3 billion as of May 2021. The company has a strong balance sheet with cash and cash equivalents of approximately $1.1 billion as of March 2021.

Cronos Group’s Peace Naturals brand is a leading Canadian cannabis brand. The company’s Original BC brand is a leading Canadian cannabis brand. Cronos Group’s Whistler Medical Marijuana Company is a leading Canadian medical cannabis company.

Cronos Group has a diversified portfolio of products and brands. The company’s products include dried cannabis, cannabis oils, and cannabis capsules. Cronos Group’s brands include Peace Naturals, Original BC, and Whistler Medical Marijuana Company.

Cronos Group has a strong management team with a track record of success in the cannabis industry. The company’s management team includes Michael Gorenstein, Cronos Group’s Chairman, President, and CEO, and Adam Greenstein, Cronos Group’s Chief Operating Officer.

Cronos Group is well-positioned to succeed in the global cannabis industry. The company has a strong balance sheet, a diversified portfolio of products and brands, and a management team with a track record of success in the cannabis industry.

OrganiGram Holdings Inc. (OGI)

OrganiGram Holdings Inc (OGI) is a Canadian producer of medical marijuana. The company is headquartered in Moncton, New Brunswick, and its shares are traded on the Toronto Stock Exchange and the Nasdaq Global Market.

OrganiGram is a leading producer of medical marijuana in Canada. The company’s products are available in all 10 provinces and 2 territories. OrganiGram’s products are sold under the Organi brand name and are available in a variety of formats, including dried flowers, oils, and capsules.

OrganiGram is a vertically integrated company, with operations spanning from seed to sale. The company has a state-of-the-art production facility, which is located in Moncton, New Brunswick. OrganiGram’s facility is one of the most technologically advanced in the world and is capable of producing high-quality, consistent products.

The company has a strong management team with a proven track record in the cannabis industry. OrganiGram’s CEO, Greg Engel, is a former executive at Canopy Growth Corporation (CGC), one of the largest cannabis companies in the world.

OrganiGram is well-positioned to capitalize on the growing global demand for medical marijuana. The company’s products are available in Canada, the European Union, and Australia. OrganiGram has a sales and distribution agreement with German pharmaceutical company, Bionorica SE, which gives the company access to the German market.

OrganiGram has a strong balance sheet, with cash and cash equivalents of CAD$245 million as of December 31, 2020. The company has no debt and is well-positioned to invest in growth opportunities.

OrganiGram Holdings Inc is a Canadian stock to watch in 2022.

The Green Organic Dutchman Holdings Ltd. (TGOD)

The Green Organic Dutchman Holdings Ltd (TGOD) is a Canadian licensed producer of medical cannabis. The company was founded in 2012 by a team of organic farmers, scientists, and business professionals with a passion for developing sustainable, organic, and natural solutions for people and the planet.

TGOD’s mission is to bring the best of cannabis to the world by producing the highest quality, organic, and sustainable cannabis products. The company’s products are sold in over 1,000 stores across Canada and are available online.

TGOD is one of the few licensed producers with a fully-funded expansion plan that includes a 400,000 sq. ft. facility in Ancaster, Ontario, a 1,000,000 sq. ft. facility in Hamilton, Ontario, and a 38,000 sq. ft. facility in Quebec.

The company is also expanding internationally with operations in Jamaica and Europe. TGOD’s products are available in over 1,000 stores across Canada and online.

The company has a strong focus on research and development and has partnered with leading research institutes, such as the University of Guelph and McMaster University. TGOD is committed to improving the quality of life for people and the planet by producing the highest quality, organic, and sustainable cannabis products.

Supreme Cannabis Company Inc. (SPRWF)

The Supreme Cannabis Company Inc. (TSX: SPRWF) is a Canadian diversified cannabis company and one of the world’s largest licensed producers of premium cannabis. They develop and sell products under the brand names “Supreme”, “7ACRES”, “ Blissco”, and “Khalifa Kush Enterprises”. The company was founded in 2014 and is headquartered in Toronto, Canada.

The company’s core purpose is to empower people to live their best lives through cannabis. They achieve this by producing high-quality products, building strong brands, and creating a great customer experience. The company is led by a team of experienced executives with a deep understanding of the global cannabis industry.

The company’s portfolio of brands includes:

• Supreme: A premium lifestyle cannabis brand that offers a range of high-quality products

• 7ACRES: A craft cannabis brand that produces small-batch, hand-crafted cannabis

• Blissco: A wellness cannabis brand that provides CBD-rich products

• Khalifa Kush Enterprises: A premium cannabis brand that offers products developed in collaboration with world-renowned rapper Wiz Khalifa

The company’s products are available in a variety of formats, including dried flower, pre-rolls, oils, and capsules. They are sold through a network of retail partners across Canada and online.

The company has a diversified business model with a focus on innovation. They are committed to investing in research and development to bring new products and brands to market. They are also expanding their international footprint to bring their products to new markets around the world.

The Supreme Cannabis Company is well-positioned to succeed in the global cannabis market. They have a strong portfolio of brands, a diversified business model, and a commitment to innovation. They are a company to watch in the cannabis industry.

H

The cannabis industry is expected to grow exponentially in the next few years. This makes it a great time to invest in cannabis stocks. But with so many options out there, it can be hard to know which ones to buy.

Here are 9 of the best cannabis stocks to buy in 2022:

1. Aurora Cannabis (ACB)

Aurora Cannabis is one of the largest cannabis companies in the world. It is headquartered in Canada and operates in 24 countries. Aurora produces and sells a variety of cannabis products, including dried flower, oils, and capsules. It also has a strong presence in the U.S. CBD market.

2. Canopy Growth (CGC)

Canopy Growth is another large Canadian cannabis company. It is the largest producer of cannabis in the world. Canopy Growth sells a variety of cannabis products, including dried flower, oils, and edibles. It also has a strong presence in the U.S. CBD market.

3. Aphria (APH)

Aphria is a Canadian cannabis company that produces and sells a variety of cannabis products, including dried flower, oils, and capsules. Aphria has a strong presence in the Canadian cannabis market and is expanding into the U.S. and European markets.

4. Tilray (TLRY)

Tilray is a Canadian cannabis company that produces and sells a variety of cannabis products, including dried flower, oils, and capsules. Tilray has a strong presence in the Canadian cannabis market and is expanding into the U.S. and European markets.

5. Cronos Group (CRON)

Cronos Group is a Canadian cannabis company that produces and sells a variety of cannabis products, including dried flower, oils, and edibles. Cronos Group has a strong presence in the Canadian cannabis market and is expanding into the U.S. market.

6. Green Organic Dutchman (TGOD)

Green Organic Dutchman is a Canadian cannabis company that produces and sells a variety of organic cannabis products, including dried flower, oils, and capsules. Green Organic Dutchman has a strong presence in the Canadian cannabis market and is